Restatement of Previously Issued Financial Statements - Schedule of Restatement of Previously Issued Financial Statements - Condensed Consolidated Statements Of Comprehensive Income (Loss) (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenue:
Revenue	$ 154,871	$ 141,192	$ 466,892	$ 465,741
Costs and operating expenses:
Cost of product revenue	77,383	104,634	231,088	265,786
Research and development	9,710	10,577	31,523	32,437
Selling, general and administrative	75,610	55,582	202,894	160,954
Contingent consideration	0	(34,292)	0	(31,266)
Total costs and operating expenses	162,703	136,501	465,505	427,911
Income from operations	(7,832)	4,691	1,387	37,830
Other income (expenses):
Investment income	9,130	6,662	27,534	18,112
Interest expense	(5,122)	(408)	(15,269)	(1,227)
Amortization of debt issuance costs	(429)	(459)	(1,432)	(1,373)
Other income (expenses)	3,104	895	(647)	1,500
Other income (expenses), net	6,683	6,690	10,186	17,012
Income before income taxes	(1,149)	11,381	11,573	54,842
Income tax (benefit) provision	(495)	(5,542)	3,218	2,796
Net income	$ (654)	$ 16,923	$ 8,355	$ 52,046
Earnings per share:
Basic	$ (0.01)	$ 0.3	$ 0.15	$ 0.93
Diluted (Note 13)	$ (0.01)	$ 0.3	$ 0.15	$ 0.91
Weighted average common shares outstanding:
Basic	56,012	55,766	55,896	55,688
Diluted (Note 13)	56,012	56,940	56,315	56,933
Net income	$ (654)	$ 16,923	$ 8,355	$ 52,046
Other comprehensive income (loss):
Foreign currency translation adjustment	9,822	(5,880)	3,185	(8,972)
Comprehensive income	9,168	11,043	11,540	43,074
Product
Revenue:
Revenue	154,834	141,156	466,784	465,630
Royalty and other revenue
Revenue:
Revenue	$ 37	36	$ 108	111
Previously Reported
Revenue:
Revenue		141,192		483,021
Costs and operating expenses:
Cost of product revenue		104,634		265,786
Research and development		10,577		32,437
Selling, general and administrative		55,465		160,601
Contingent consideration		(34,292)		(31,266)
Total costs and operating expenses		136,384		427,558
Income from operations		4,808		55,463
Other income (expenses):
Investment income		6,662		18,112
Interest expense		(269)		(813)
Amortization of debt issuance costs		(459)		(1,373)
Other income (expenses)		895		1,500
Other income (expenses), net		6,829		17,426
Income before income taxes		11,637		72,889
Income tax (benefit) provision		(6,535)		5,824
Net income		$ 18,172		$ 67,065
Earnings per share:
Basic		$ 0.33		$ 1.2
Diluted (Note 13)		$ 0.32		$ 1.18
Weighted average common shares outstanding:
Basic		55,766		55,688
Diluted (Note 13)		56,940		56,933
Net income		$ 18,172		$ 67,065
Other comprehensive income (loss):
Foreign currency translation adjustment		(6,382)		(9,177)
Comprehensive income		11,790		57,888
Previously Reported | Product
Revenue:
Revenue		141,156		482,910
Previously Reported | Royalty and other revenue
Revenue:
Revenue		36		111
Revenue Adjustments
Revenue:
Revenue		0		(17,280)
Costs and operating expenses:
Cost of product revenue		0		0
Research and development		0		0
Selling, general and administrative		0		0
Contingent consideration		0		0
Total costs and operating expenses		0		0
Income from operations		0		(17,280)
Other income (expenses):
Investment income		0		0
Interest expense		0		0
Amortization of debt issuance costs		0		0
Other income (expenses)		0		0
Other income (expenses), net		0		0
Income before income taxes		0		(17,280)
Income tax (benefit) provision		1,053		(2,849)
Net income		$ (1,053)		$ (14,431)
Earnings per share:
Basic		$ (0.02)		$ (0.26)
Diluted (Note 13)		$ (0.02)		$ (0.25)
Weighted average common shares outstanding:
Basic		0		0
Diluted (Note 13)		0		0
Net income		$ (1,053)		$ (14,431)
Other comprehensive income (loss):
Foreign currency translation adjustment		502		205
Comprehensive income		(551)		(14,226)
Revenue Adjustments | Product
Revenue:
Revenue		0		(17,280)
Revenue Adjustments | Royalty and other revenue
Revenue:
Revenue		0		0
Other Adjustments
Revenue:
Revenue		0		0
Costs and operating expenses:
Cost of product revenue		0		0
Research and development		0		0
Selling, general and administrative		117		353
Contingent consideration		0		0
Total costs and operating expenses		117		353
Income from operations		(117)		(353)
Other income (expenses):
Investment income		0		0
Interest expense		(139)		(414)
Amortization of debt issuance costs		0		0
Other income (expenses)		0		0
Other income (expenses), net		(139)		(414)
Income before income taxes		(256)		(767)
Income tax (benefit) provision		(60)		(179)
Net income		$ (196)		$ (588)
Earnings per share:
Basic		$ (0.01)		$ (0.01)
Diluted (Note 13)		$ 0		$ (0.02)
Weighted average common shares outstanding:
Basic		0		0
Diluted (Note 13)		0		0
Net income		$ (196)		$ (588)
Other comprehensive income (loss):
Foreign currency translation adjustment		0		0
Comprehensive income		(196)		(588)
Other Adjustments | Product
Revenue:
Revenue		0		0
Other Adjustments | Royalty and other revenue
Revenue:
Revenue		$ 0		$ 0